Fed. Circ. Won't Reconsider Reviving Bard Patents
The Federal Circuit announced Thursday it won't rethink a panel's February decision that revived a trio of patents owned by C.R. Bard Inc. and Bard Peripheral Vascular Inc. covering medical injection...To view the full article, register now.
Already a subscriber? Click here to view full article